Trade of the SELL TECH · April McClain Delaney
Bio-Techne Corp - Common Stock (TECH)
Routine managed-account rebalancing
| Inside their committee's jurisdiction |
|
0/32 |
| Isolated decision, not a bulk rebalance |
|
18/22 |
|
Small, thinly-followed company
Nobody needs inside information to buy a mega-cap.
|
|
6/10 |
| Member's own account |
|
0/8 |
| Committee chair or ranking member |
|
0/8 |
|
A name they had never held before
A first purchase is a decision; the ninth purchase of the same holding is a standing order.
|
|
0/8 |
|
Unusually large for this member
Against their own median trade, not an absolute threshold - and capped, because trades beyond 3x did worse, not better.
|
|
0/6 |
| Position size |
|
0/3 |
| Leveraged instrument (option) |
|
0/3 |
A high grade is not an allegation. Every input is public, and buying into an industry you work on daily is ordinary expertise. What the trade actually returned is deliberately excluded from this score and shown separately below.
It is also not a forecast. Measured across every settled trade, A-graded ones did not beat E-graded ones to any significant degree — the method page prints the table. This score says a trade looks like a decision rather than administration, and nothing more.
The filing it came from
filed in 32 days Towards the 45-day statutory limit.
The position this closes
| Bought | Disclosed size | Held | Return | vs S&P |
|---|---|---|---|---|
| 29 Apr 2025 | $1,001 - $15,000 | 94 d | +8.9% | -3.6% |
What a follower should do: keep holding — 245 days still to run.
The member is out, but the tracked position is not due to close yet. Following members out of positions was tested and it lost 6.50 points against holding the full term - disclosure arrives too late to be worth acting on.
Matched oldest-lot-first on disclosed value within this account. Filings give a range, never a share count, so the pairing reads the documents rather than reconstructing the portfolio.
This is a sale, and the strategy does not act on it. It records the member closing a position; it is not a short signal and not an instruction to sell. Exiting when members disclose selling, rather than at twelve months, cut in-remit alpha from +6.76% to +3.57% — a cost of 6.50 points on the trades it changed. See the method.
This filing disclosed 16 transactions in total, of which 5 share this trade date (01 Aug 2025).
Filed 02 Sep 2025 · source PDF
Price
52-week range $43.22 – $72.29. The marker is the entry: the first market open after this filing became public.
Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science …
| Sector | Healthcare |
| Industry | Biotechnology |
| Analyst range | $50 – $73 |
| Employees | 3,000 |
| Instrument | ST |
| Jurisdiction tags | healthcarepharma |
Outside this member's committee jurisdiction (aerospace, agriculture, commodities, technology).
Expressing this with options
An illustration, not a recommendation: the nearest listed expiry to a twelve-month horizon, struck near the money. Chains are live — Yahoo publishes no historical chains, so this is priced today, not when the filing was made, and the move it describes may already have happened.
Loading chain…
Outcome
| Held | This trade | S&P 500 | Alpha |
|---|---|---|---|
| 1m | — | — | — |
| 3m | — | — | — |
| 6m | — | — | — |
| 12m 1yr | — | — | — |
| 18m | — | — | — |
| 24m | — | — | — |
| 36m | — | — | — |
| 48m | — | — | — |
| 60m 5yr | — | — | — |
Measured from the first open after disclosure — the earliest anyone reading this could have acted. The highlighted now row sits at its true place in the sequence, so where it falls tells you how long the position has run. The last 9 rows are blank because those windows have not closed yet: this trade was entered —, so anything longer than that is still running.
Other congressional trades in TECH
| Grade | Date | Member | Side | Amount |
|---|---|---|---|---|
| D | 08 Apr 2026 | April McClain Delaney | sale | $1,001 - $15,000 |
| D | 26 Mar 2026 | April McClain Delaney | sale partial | $1,001 - $15,000 |
| E | 24 Feb 2026 | April McClain Delaney | sale partial | $1,001 - $15,000 |
| E | 28 Jan 2026 | April McClain Delaney | sale partial | $1,001 - $15,000 |
| E | 05 Dec 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 02 Dec 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 22 Oct 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| D | 26 May 2025 | April McClain Delaney | sale partial | $1,001 - $15,000 |
| E | 29 Apr 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| D | 09 Apr 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 08 Apr 2025 | Rob Bresnahan | sale | $1,001 - $15,000 |
| E | 01 Apr 2025 | Julie Johnson | sale | $1,001 - $15,000 |
| E | 25 Feb 2025 | Rob Bresnahan | purchase | $1,001 - $15,000 |
| C | 13 Oct 2020 | Greg Gianforte | sale partial | $1,001 - $15,000 |